Bond v. Clover Health Investments, Corp. et al

  1. October 03, 2023

    Pomerantz Plucks $5.5M Fee For Clover Health Investor Deal

    A legal team headed up by Pomerantz LLP will receive a $5.5 million fee for its work representing investors in Medicare Advantage insurance provider Clover Health Investments Corp., alleging the company concealed a U.S. Department of Justice investigation it faced in the lead-up to its go-public merger with a special purpose acquisition company.

  2. April 25, 2023

    Clover Health To Pay $22M In Investor Suit Over DOJ Probe

    Medicare Advantage insurance provider Clover Health Investments Corp. has agreed to a $22 million settlement deal that resolves claims it covered up a U.S. Department of Justice probe as it prepared to go public via a merger with a special-purpose acquisition company.

  3. March 01, 2022

    Clover Health Must Face Shareholders' Suit Over DOJ Probe

    Medicare Advantage insurance provider Clover Health Investments Corp. can't shake investors' claims it improperly concealed Justice Department scrutiny of its business practices, according to a federal judge in Nashville.

  4. April 07, 2021

    Hagens Berman, Faruqi, Others Vying To Rep Clover Investors

    Several securities-focused law firms including Pomerantz LLP, Faruqi & Faruqi and Labaton Sucharow LLP seek to represent investors in a proposed class action alleging Medicare Advantage provider Clover Health Investments Corp. failed to disclose that federal prosecutors were scrutinizing the company as it went public via merger with a special purpose acquisition company.

  5. February 08, 2021

    Clover Health Investor Says Co. Hid DOJ Probe During Merger

    Medicare Advantage provider Clover Health Investments Corp. was hit Friday with a proposed securities class action in Nashville federal court alleging the company failed to disclose that federal prosecutors were scrutinizing the company as it went public via merger with a special purpose acquisition company.